<bill session="116" type="h" number="1520" updated="2022-11-01T17:03:27Z">
  <state datetime="2020-12-22">ENACTED:SIGNED</state>
  <status>
    <unknown datetime="2020-12-22"/>
  </status>
  <introduced datetime="2019-03-05"/>
  <titles>
    <title type="display">Further Extension of Continuing Appropriations Act, 2021</title>
    <title type="official" as="amended by house">Making further continuing appropriations for fiscal year 2021, and for other purposes.</title>
    <title type="official" as="introduced">To amend the Public Health Service Act to provide for the publication of a list of licensed biological products, and for other purposes.</title>
    <title type="short" as="introduced">Purple Book Continuity Act of 2019</title>
    <title type="short" as="reported to house">Purple Book Continuity Act of 2019</title>
    <title type="short" as="enacted">Further Extension of Continuing Appropriations Act, 2021</title>
    <title type="short" as="passed senate">Purple Book Continuity Act of 2020</title>
    <title type="short">Purple Book Continuity Act of 2020</title>
    <title type="short" as="passed house">Purple Book Continuity Act of 2019</title>
    <title type="short" as="passed house">Purple Book Continuity Act of 2019</title>
  </titles>
  <sponsor bioguide_id="E000215"/>
  <cosponsors>
    <cosponsor bioguide_id="B001248" joined="2019-04-01"/>
    <cosponsor bioguide_id="C001067" joined="2019-04-02"/>
    <cosponsor bioguide_id="C001119" joined="2019-03-26"/>
    <cosponsor bioguide_id="D000624" joined="2019-03-26"/>
    <cosponsor bioguide_id="K000379" joined="2019-03-26"/>
    <cosponsor bioguide_id="M001163" joined="2019-04-01"/>
    <cosponsor bioguide_id="M001207" joined="2019-04-30"/>
    <cosponsor bioguide_id="P000034" joined="2019-03-26"/>
    <cosponsor bioguide_id="R000599" joined="2019-03-26"/>
    <cosponsor bioguide_id="R000515" joined="2019-03-26"/>
    <cosponsor bioguide_id="V000133" joined="2019-04-02"/>
    <cosponsor bioguide_id="W000791" joined="2019-04-04"/>
  </cosponsors>
  <actions>
    <action datetime="2019-03-05">
      <text>Introduced in House</text>
    </action>
    <action datetime="2019-03-05" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2019-03-06">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2019-03-27">
      <text>Subcommittee Consideration and Mark-up Session Held.</text>
    </action>
    <action datetime="2019-03-27">
      <text>Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .</text>
    </action>
    <action datetime="2019-04-03">
      <text>Committee Consideration and Mark-up Session Held.</text>
    </action>
    <action datetime="2019-04-03" state="REPORTED">
      <text>Ordered to be Reported (Amended) by Voice Vote.</text>
    </action>
    <action datetime="2019-05-03">
      <text>Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-48.</text>
    </action>
    <calendar datetime="2019-05-03" calendar="Union" number="26">
      <text>Placed on the Union Calendar, Calendar No. 26.</text>
    </calendar>
    <action datetime="2019-05-08T12:18:26-04:00">
      <text>Ms. Eshoo moved to suspend the rules and pass the bill, as amended.</text>
    </action>
    <action datetime="2019-05-08T12:18:36-04:00">
      <text>Considered under suspension of the rules.</text>
      <reference ref="CR H3485-3486" label="consideration"/>
    </action>
    <action datetime="2019-05-08T12:18:37-04:00">
      <text>DEBATE - The House proceeded with forty minutes of debate on H.R. 1520.</text>
    </action>
    <action datetime="2019-05-08T12:25:13-04:00">
      <text>At the conclusion of debate, the chair put the question on the motion to suspend the rules. Ms. Eshoo objected to the vote on the grounds that a quorum was not present. Further proceedings on the motion were postponed. The point of no quorum was considered as withdrawn.</text>
    </action>
    <action datetime="2019-05-08T14:00:35-04:00">
      <text>Considered as unfinished business.</text>
      <reference ref="CR H3491-3492" label="consideration"/>
    </action>
    <vote how="roll" type="vote" roll="188" datetime="2019-05-08T14:11:57-04:00" where="h" result="pass" suspension="1" state="PASS_OVER:HOUSE">
      <text>On motion to suspend the rules and pass the bill, as amended Agreed to by recorded vote (2/3 required): 421 - 0 (Roll no. 188).</text>
      <reference ref="CR H3485-3486" label="text"/>
    </vote>
    <action datetime="2019-05-08T14:11:58-04:00">
      <text>Motion to reconsider laid on the table Agreed to without objection.</text>
    </action>
    <action datetime="2019-05-09">
      <text>Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
    <action datetime="2020-12-10">
      <text>Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.</text>
    </action>
    <action datetime="2020-12-10">
      <text>Measure laid before Senate by unanimous consent.</text>
      <reference ref="CR S7396-7397" label="consideration"/>
    </action>
    <vote how="by Unanimous Consent" type="vote2" datetime="2020-12-10" where="s" result="pass" state="PASS_BACK:SENATE">
      <text>Passed Senate with an amendment by Unanimous Consent.</text>
      <reference ref="CR S7396-7397" label="text of amendment in the nature of a substitute"/>
    </vote>
    <action datetime="2020-12-11">
      <text>Message on Senate action sent to the House.</text>
    </action>
    <action datetime="2020-12-21T18:11:00-05:00">
      <text>House agreed to the Senate amendment with an amendment pursuant to the provisions of H.Res. 1271.</text>
      <reference ref="CR H7300" label="consideration"/>
      <reference ref="CR H7300" label="text of amendment in the nature of a substitute"/>
    </action>
    <action datetime="2020-12-21">
      <text>Message on House action received in Senate and at desk: House amendment to Senate amendment.</text>
    </action>
    <vote how="by Voice Vote" type="pingpong" datetime="2020-12-21" where="s" result="pass" state="PASSED:BILL">
      <text>Senate agreed to the House amendment to the Senate amendment to H.R. 1520 by Voice Vote.</text>
      <reference ref="CR S7923" label="consideration"/>
    </vote>
    <action datetime="2020-12-21">
      <text>Message on Senate action sent to the House.</text>
    </action>
    <topresident datetime="2020-12-21">
      <text>Presented to President.</text>
    </topresident>
    <signed datetime="2020-12-22" state="ENACTED:SIGNED">
      <text>Signed by President.</text>
    </signed>
    <enacted number="116-246" type="public" datetime="2020-12-22">
      <text>Became Public Law No: 116-246.</text>
    </enacted>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Discharged, Referral"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Reporting, Markup, Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Reporting, Markup, Referral"/>
  </committees>
  <relatedbills>
    <bill session="116" type="h" number="19" relation="unknown"/>
    <bill session="116" type="hj" number="107" relation="unknown"/>
    <bill session="116" type="hj" number="110" relation="unknown"/>
    <bill session="116" type="hc" number="128" relation="unknown"/>
    <bill session="116" type="hr" number="1271" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Economics and public finance"/>
    <term name="Appropriations"/>
    <term name="Congressional oversight"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Executive agency funding and structure"/>
    <term name="Government information and archives"/>
    <term name="Health"/>
    <term name="Licensing and registrations"/>
  </subjects>
  <amendments>
    <amendment number="s2699"/>
  </amendments>
  <summary date="2021-09-12T16:33:13Z" status="Introduced in House">Purple Book Continuity Act of 2019

This bill modifies requirements for the Food and Drug Administration to publish information regarding biological products.</summary>
  <committee-reports>
    <report>H. Rept. 116-48</report>
  </committee-reports>
</bill>
